Lembo G, Iaccarino G, Rendina V, Volpe M, Trimarco B
Department of Internal Medicine, School of Medicine, Federico II University, Naples, Italy.
Hypertension. 1994 Oct;24(4):429-38. doi: 10.1161/01.hyp.24.4.429.
We investigated the mechanisms underlying the insulin-induced attenuation of sympathetic forearm vasoconstriction in healthy humans. In 5 subjects, we applied 20 mm Hg lower body negative pressure for 30 minutes in control conditions and during a 60-minute infusion of insulin (0.05 mU/kg per minute) in the brachial artery and measured forearm norepinephrine kinetics and hemodynamics. In 11 subjects, we applied graded lower body negative pressure at 5, 10, 15, and 20 mm Hg for 5 minutes each in control conditions and during the simultaneous intrabrachial administration of insulin (0.05 mU/kg per minute) (5 subjects) or insulin plus ouabain (3.5 micrograms/min per liter) (6 subjects) to investigate whether insulin acts through a potentiation of the vascular smooth muscle Na+,K(+)-ATPase. To assess a possible effect of insulin on a specific adrenergic receptor pathway, in a further study group we evaluated (1) the forearm vascular response to intrabrachial infusion of the alpha 1-adrenergic receptor agonist phenylephrine (0.5, 1, and 2 micrograms/kg per minute; n = 7) and of the alpha 2-adrenergic receptor agonist BHT-933 (0.5, 1, 2, and 4 micrograms/kg per minute; n = 9), and (2) the effects of intra-arterial infusion of prazosin (0.5 microgram/100 mL per minute) alone or combined with insulin on the forearm vascular response to graded lower body negative pressure (7 subjects). Insulin blunted the peak increase in forearm vascular resistance (from 13 +/- 2 to 6 +/- 2 U, P < .05) but not the rise in forearm norepinephrine spillover induced by 20 mm Hg lower body negative pressure (from 8.3 +/- 1.8 to 11.1 +/- 3.5 pmol/min per liter, P = NS). Ouabain administration did not prevent the insulin-induced attenuation of the forearm vasoconstrictive response to graded lower body negative pressure. Insulin infusion in the brachial artery did not modify the forearm vasoconstriction induced by intra-arterial infusion of phenylephrine but significantly reduced the increase in forearm vascular resistance induced by BHT-933 (F = 6.111, P < .001). Finally, intra-arterial infusion of prazosin significantly attenuated the forearm vasoconstriction induced by graded lower body negative pressure. The residual vasoconstrictive response was abolished by insulin infusion. Taken together, these findings suggest that insulin interacts with the sympathetic nervous system at the vascular level predominantly through the alpha 2-adrenergic vasoconstrictive pathway.
我们研究了健康人体中胰岛素诱导的前臂交感神经血管收缩减弱的潜在机制。在5名受试者中,我们在对照条件下以及在肱动脉内输注胰岛素(0.05 mU/kg每分钟)60分钟期间,施加20 mmHg的下体负压30分钟,并测量前臂去甲肾上腺素动力学和血流动力学。在11名受试者中,我们在对照条件下以及在肱动脉内同时给予胰岛素(0.05 mU/kg每分钟)(5名受试者)或胰岛素加哇巴因(3.5微克/分钟每升)(6名受试者)期间,分别施加5、10、15和20 mmHg的分级下体负压各5分钟,以研究胰岛素是否通过增强血管平滑肌钠钾ATP酶起作用。为了评估胰岛素对特定肾上腺素能受体途径的可能影响,在另一个研究组中,我们评估了:(1)前臂血管对肱动脉内输注α1肾上腺素能受体激动剂去氧肾上腺素(0.5、1和2微克/千克每分钟;n = 7)和α2肾上腺素能受体激动剂BHT - 933(0.5、1、2和4微克/千克每分钟;n = 9)的反应;(2)动脉内输注哌唑嗪(0.5微克/100 mL每分钟)单独或与胰岛素联合对前臂血管对分级下体负压反应的影响(7名受试者)。胰岛素减弱了前臂血管阻力的峰值增加(从13±2到6±2 U,P <.05),但没有减弱20 mmHg下体负压诱导的前臂去甲肾上腺素溢出的增加(从8.3±1.8到11.1±3.5 pmol/分钟每升,P =无显著差异)。给予哇巴因并不能预防胰岛素诱导的前臂血管对分级下体负压收缩反应的减弱。肱动脉内输注胰岛素并未改变动脉内输注去氧肾上腺素诱导的前臂血管收缩,但显著降低了BHT - 933诱导的前臂血管阻力增加(F = 6.111,P <.001)。最后,动脉内输注哌唑嗪显著减弱了分级下体负压诱导的前臂血管收缩。残余的血管收缩反应被胰岛素输注消除。综上所述,这些发现表明胰岛素主要通过α2肾上腺素能血管收缩途径在血管水平与交感神经系统相互作用。